GSK-3 and the neurodevelopmental hypothesis of schizophrenia

Nitsan Kozlovsky, R.H Belmaker, Galila Agam

Open source

DOI: 10.1016/s0924-977x(01)00131-6
Published: 2002-02
Container: European Neuropsychopharmacology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0924-977x-01-00131-6,
  title = {GSK-3 and the neurodevelopmental hypothesis of schizophrenia},
  author = {Nitsan Kozlovsky and R.H Belmaker and Galila Agam},
  year = {2002},
  journal = {European Neuropsychopharmacology},
  doi = {10.1016/s0924-977x(01)00131-6},
  url = {https://doi.org/10.1016/s0924-977x(01)00131-6}
}

RIS

TY  - JOUR
TI  - GSK-3 and the neurodevelopmental hypothesis of schizophrenia
AU  - Nitsan Kozlovsky
AU  - R.H Belmaker
AU  - Galila Agam
PY  - 2002
JO  - European Neuropsychopharmacology
DO  - 10.1016/s0924-977x(01)00131-6
UR  - https://doi.org/10.1016/s0924-977x(01)00131-6
ER  -

APA

Kozlovsky, N., Belmaker, R., & Agam, G. (2002). GSK-3 and the neurodevelopmental hypothesis of schizophrenia. European Neuropsychopharmacology. https://doi.org/10.1016/s0924-977x(01)00131-6

Source records

crossref · retrieved 2026-09-26T12:35:05.627Z